2025-04-13 - Analysis Report
## Salesforce Inc. (CRM) Stock Analysis Report

**0. Key Figures & Initial Analysis:**

Salesforce (CRM) is a cloud-based software company providing customer relationship management (CRM) services.  The provided data shows a significant underperformance compared to the S&P 500 (VOO).  Further analysis is required to determine the reasons behind this divergence.

**1. Performance Comparison with S&P 500:**

* **CRM Cumulative Return:** 21.86%
* **VOO (S&P 500) Cumulative Return:** 66.36%
* **Return Difference:** -44.5%
* **Relative Divergence:** 15.9% (This indicates CRM's underperformance relative to its historical range against the S&P 500.)

The table below shows the CAGR (Compound Annual Growth Rate), Maximum Drawdown (MDD), Alpha, Beta, and Market Capitalization (Cap) for various periods:

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 41.0% | 59.0% | 12.0% | -0.0 | 97.5 |
| 2016-2018  | 43.0% | 64.9% | 25.0% | 0.0 | 130.7 |
| 2017-2019  | 43.0% | 64.9% | 13.0% | 0.5 | 155.2 |
| 2018-2020  | 32.0% | 64.9% | 7.0% | 0.5 | 212.3 |
| 2019-2021  | 44.0% | 61.2% | -11.0% | 0.6 | 242.5 |
| 2020-2022  | -93.0% | 69.2% | -99.0% | 0.7 | 126.5 |
| 2021-2023  | -46.0% | 69.2% | -63.0% | 2.0 | 251.1 |
| 2022-2024  | -42.0% | 69.2% | -58.0% | 2.3 | 320.8 |
| 2023-2025  | 18.0% | 80.6% | 4.0% | 2.5 | 245.1 |


Note the significant negative CAGR and high MDD in 2020-2022 and 2021-2023, indicating periods of substantial underperformance.  The increasing Beta suggests increasing market sensitivity over time.  The Alpha values are inconsistent, sometimes positive and sometimes negative, reflecting varying degrees of outperformance or underperformance relative to the market.


**2. Recent Price Movement:**

* **Closing Price:** $255.0
* **5-Day Moving Average:** $252.46
* **20-Day Moving Average:** $268.19
* **60-Day Moving Average:** $300.13

The price is below all three moving averages, suggesting a potential downtrend.

**3. Technical Indicators & Expected Return:**

* **Market Risk Indicator (MRI):** 0.47 (High Risk)
* **RSI:** 33.30 (Oversold territory, suggesting potential for a bounce)
* **PPO:** -0.08 (Negative, indicating bearish momentum)
* **Recent Relative Divergence Change (20-day):** 0.0 (-) (Short-term downward trend)
* **Expected Return:** -170.5% (This extremely negative figure needs further clarification and context.  It's likely representing a potential downside scenario, not a realistic expectation for long-term investment.)

The negative price change of -$0.05 does not suggest a significant event requiring additional comment.


**4. Recent Earnings Analysis:**

| Date       | EPS  | Revenue       |
|------------|------|----------------|
| 2024-12-04 | 1.6  | $9.44 B        |
| 2024-08-29 | 1.48 | $9.32 B        |
| 2024-05-30 | 1.58 | $9.13 B        |
| 2023-11-30 | 1.26 | $8.72 B        |
| 2024-12-04 | 1.26 | $8.72 B        |

There's a duplicate entry for 2024-12-04.  Excluding the duplicate, revenue shows a generally increasing trend, while EPS fluctuates but generally shows improvement. Further analysis with complete data is needed for conclusive statements.

**5. Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-01-31 | $9.99B | 77.81% |
| 2024-10-31 | $9.44B | 77.71% |
| 2024-07-31 | $9.32B | 76.85% |
| 2024-04-30 | $9.13B | 76.33% |
| 2024-01-31 | $9.29B | 76.87% |

Revenue shows consistent growth, while profit margins remain relatively high and stable.

**Capital and Profitability:**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-01-31 | $61.17B | 2.79% |
| 2024-10-31 | $58.52B | 2.61% |
| 2024-07-31 | $57.63B | 2.48% |
| 2024-04-30 | $59.68B | 2.57% |
| 2024-01-31 | $59.65B | 2.42% |

Equity fluctuates, and ROE remains relatively consistent, indicating a stable level of profitability relative to equity.


**6. Overall Analysis:**

Salesforce (CRM) is currently underperforming the S&P 500 significantly. While recent earnings show revenue growth and healthy profit margins, the stock price is below its moving averages, suggesting a bearish trend. Technical indicators such as RSI and PPO signal potential oversold conditions and negative momentum. The -170.5% expected return is alarming and requires further investigation for clarification.  The high market risk indicator suggests caution.  A long-term investment strategy would require careful consideration of the risks involved, given its recent volatility and underperformance relative to the market.  More comprehensive analysis, including a thorough examination of the company's strategic direction and future growth prospects, is necessary for a well-informed investment decision.  The provided data alone is insufficient to make a strong buy or sell recommendation.
